Trials / Completed
CompletedNCT03292926
A Novel Analgesia Technique for ACL Reconstruction
A Randomized Controlled Trial to Evaluate a Novel Analgesia Technique for ACL Reconstruction: Adductor Canal Block With an IPACK Versus Adductor Canal Block
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 78 (actual)
- Sponsor
- Hospital for Special Surgery, New York · Academic / Other
- Sex
- All
- Age
- 13 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
A comparison of two anesthetic techniques-- the Adductor Canal Block (ACB) and the Adductor Canal Block with Infiltration of the interspace between the popliteal artery and the capsule of the posterior knee (ACB/IPACK)-- in patients undergoing bone-tendon-bone (BTB) anterior cruciate ligament (ACL) reconstruction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bupivacaine | Bupivacaine will help treat pain and sensation after ACL repair |
| DEVICE | Ultrasound | Ultrasound will guide anesthesiologist in performing the different nerve blocks |
| DRUG | Dexamethasone | Dexamethasone will be used to prolong block duration |
Timeline
- Start date
- 2017-10-04
- Primary completion
- 2020-03-06
- Completion
- 2020-04-16
- First posted
- 2017-09-26
- Last updated
- 2024-09-19
- Results posted
- 2022-05-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03292926. Inclusion in this directory is not an endorsement.